Literature DB >> 21291452

PTEN in colorectal cancer: a report on two Cowden syndrome patients.

R Kersseboom1, H J Dubbink, W E Corver, A J P van Tilburg, J W Poley, M E van Leerdam, P N Atmodimedjo, I M B H van de Laar, J M Collée, W N M Dinjens, H Morreau, A Wagner.   

Abstract

Heterozygous germline PTEN mutations cause Cowden syndrome. The risk of colorectal cancer in Cowden patients, however, remains a matter of debate. We describe two patients presenting with colorectal cancer at a young age (28 and 39 years) and dysmorphisms fitting the Cowden spectrum. Heterozygous germline mutations in PTEN were found in both patients. Moreover, analysis of the resected colorectal cancer specimens revealed loss of heterozygosity at the PTEN locus with retention of the mutated alleles, and greatly reduced or absent PTEN expression. Histologically and molecularly, the tumours showed resemblance with sporadic colorectal cancers, although they had prominent fibrotic stroma. Our data indicate that PTEN loss was involved in carcinogenesis in the two patients, supporting that colorectal cancer is part of the Cowden syndrome-spectrum. This is in line with data on sporadic colorectal cancer, mice studies and emerging epidemiological data on Cowden syndrome. Although the exact role of germline PTEN mutations in the carcinogenesis of colorectal cancer remains unclear, we think that Cowden syndrome should be in the differential diagnosis of colorectal cancer certainly in view of the possible prognostic and therapeutic consequences. Prospective follow-up and surveillance of PTEN mutation carriers from the age of 25 to 30 years in a study setting should clarify this issue.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21291452     DOI: 10.1111/j.1399-0004.2011.01639.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

1.  ACG Guidelines on Management of PTEN-Hamartoma Tumor Syndrome: Does the Evidence Support so Much so Young?

Authors:  Brandie Heald; Carol A Burke; Matthew Kalady; Charis Eng
Journal:  Am J Gastroenterol       Date:  2015-12       Impact factor: 10.864

Review 2.  Colonic manifestations of PTEN hamartoma tumor syndrome: case series and systematic review.

Authors:  Peter P Stanich; Robert Pilarski; Jonathan Rock; Wendy L Frankel; Samer El-Dika; Marty M Meyer
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

3.  Incidence, clinical features and possible etiology of early onset (≤40 years) colorectal neoplasms.

Authors:  Federica Domati; Stefania Maffei; Shaniko Kaleci; Carmela Di Gregorio; Monica Pedroni; Luca Roncucci; Piero Benatti; Giulia Magnani; Luigi Marcheselli; Luca Reggiani Bonetti; Francesco Mariani; Antonio Maria Alberti; Valerio Rossi; Maurizio Ponz de Leon
Journal:  Intern Emerg Med       Date:  2013-08-09       Impact factor: 3.397

4.  Role of SALL4 in the progression and metastasis of colorectal cancer.

Authors:  Mohammad Mahdi Forghanifard; Meysam Moghbeli; Reza Raeisossadati; Alireza Tavassoli; Afsaneh Javdani Mallak; Samaneh Boroumand-Noughabi; Mohammad Reza Abbaszadegan
Journal:  J Biomed Sci       Date:  2013-01-30       Impact factor: 8.410

5.  Hamartomatous polyposis syndromes.

Authors:  Zoran Stojcev; Pawel Borun; Jacek Hermann; Piotr Krokowicz; Wojciech Cichy; Lukasz Kubaszewski; Tomasz Banasiewicz; Andrzej Plawski
Journal:  Hered Cancer Clin Pract       Date:  2013-06-01       Impact factor: 2.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.